Despite the absence of any overt infection or definitive evidence of autoantigen-mediated immune cell activation during obesity, chronic inflammation in this state is an established instigator of several diseases such as type 2 diabetes, defective immunity, atherosclerosis, certain cancers, central nervous system dysfunction and dementia [1][2] [3] [4] . Activation of adipose tissue macrophages within fat depots is coupled with the development of obesity-induced proinflammatory state and insulin resistance 5, 6 . The activation of classically activated M1 macrophages at the expense of anti-inflammatory M2 macrophages has been causally linked to the development of adipose tissue inflammation and metabolic syndrome 7,8 , a pathophysiological state aptly termed as 'metainflammation' 9 . It is recognized that several proinflammatory cytokines 10 , including IL-1β, are implicated in disrupting insulin signaling 11 . Consistent with these data, randomized clinical trials have shown that blockade of IL-1β signaling by anakinra, a recombinant human IL-1 receptor antagonist, leads to a sustained reduction in systemic inflammation and improvement of type 2 diabetes 12,13 . Thus, while the specific release of proinflammatory cytokines by macrophages during infection is a critical mechanism for a protective immune response 14,15 , the origin of inflammation during obesity and the underlying molecular mechanisms that explain its occurrence are not fully understood.
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Despite the absence of any overt infection or definitive evidence of autoantigen-mediated immune cell activation during obesity, chronic inflammation in this state is an established instigator of several diseases such as type 2 diabetes, defective immunity, atherosclerosis, certain cancers, central nervous system dysfunction and dementia [1] [2] [3] [4] . Activation of adipose tissue macrophages within fat depots is coupled with the development of obesity-induced proinflammatory state and insulin resistance 5, 6 . The activation of classically activated M1 macrophages at the expense of anti-inflammatory M2 macrophages has been causally linked to the development of adipose tissue inflammation and metabolic syndrome 7, 8 , a pathophysiological state aptly termed as 'metainflammation' 9 . It is recognized that several proinflammatory cytokines 10 , including IL-1β, are implicated in disrupting insulin signaling 11 . Consistent with these data, randomized clinical trials have shown that blockade of IL-1β signaling by anakinra, a recombinant human IL-1 receptor antagonist, leads to a sustained reduction in systemic inflammation and improvement of type 2 diabetes 12, 13 . Thus, while the specific release of proinflammatory cytokines by macrophages during infection is a critical mechanism for a protective immune response 14, 15 , the origin of inflammation during obesity and the underlying molecular mechanisms that explain its occurrence are not fully understood.
Innate immune cells such as macrophages discriminate between infectious agents and self proteins by detecting pathogen-associated molecular patterns through expression of pattern recognition receptors such as Toll-like receptors (TLRs) and NLRs [15] [16] [17] . Emerging evidence suggests that macrophages can also recognize dangerassociated molecular patterns (DAMPs) derived from injured or damaged cells and release proinflammatory cytokines such as IL-1β (refs. 18-20) . The release of bioactive IL-1β and IL-18 from macrophages is in turn dependent on autocatalytic activation of procaspase-1 zymogen into enzymatically active 10-kDa and 20-kDa caspase-1 heterodimers [21] [22] [23] . The presence of a large N-terminal homotypic protein-protein interaction motif called caspase activation recruitment domain (CARD) is crucial for formation of multiprotein scaffolds called inflammasomes wherein caspase-1 undergoes conformational change required for its cleavage and full activation [18] [19] [20] 24 .
Structurally, the NLR proteins contain N-terminal CARD or pyrin domains needed for homotypic protein-protein interaction, an intermediate nucleotide binding self-oligomerization NACHT domain and a C-terminal domain containing leucine-rich repeats [18] [19] [20] 24 . Among the NLR family members, the Nlrp3 inflammasome has been implicated in sensing the non-microbial-originated DAMPs such as extracellular ATP, urate crystals, asbestos, silica and β-amyloid [25] [26] [27] [28] . The assembly of the Nlrp3 inflammasome requires interaction of the pyrin domain of ASC (apoptosis-associated speck-like protein containing carboxy-terminal CARD) with the pyrin domain of Nlrp3,
The emergence of chronic inflammation during obesity in the absence of overt infection or well-defined autoimmune processes is a puzzling phenomenon. The Nod-like receptor (NLR) family of innate immune cell sensors, such as the nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (Nlrp3, but also known as Nalp3 or cryopyrin) inflammasome are implicated in recognizing certain nonmicrobial originated 'danger signals' leading to caspase-1 activation and subsequent interleukin-1b (IL-1b) and IL-18 secretion. We show that calorie restriction and exercise-mediated weight loss in obese individuals with type 2 diabetes is associated with a reduction in adipose tissue expression of Nlrp3 as well as with decreased inflammation and improved insulin sensitivity. We further found that the Nlrp3 inflammasome senses lipotoxicity-associated increases in intracellular ceramide to induce caspase-1 cleavage in macrophages and adipose tissue. Ablation of Nlrp3 in mice prevents obesity-induced inflammasome activation in fat depots and liver as well as enhances insulin signaling. Furthermore, elimination of Nlrp3 in obese mice reduces IL-18 and adipose tissue interferon-g (IFN-g) expression, increases naive T cell numbers and reduces effector T cell numbers in adipose tissue. Collectively, these data establish that the Nlrp3 inflammasome senses obesity-associated danger signals and contributes to obesity-induced inflammation and insulin resistance. a r t i c l e s 1 8 0 VOLUME 17 | NUMBER 2 | FEBRUARY 2011 nature medicine and a functional inflammasome complex is formed through CARD-CARD interaction of ASC with procaspase-1 (refs. 24, 29) . It has been shown that obesity-induced elevation in specific saturated free fatty acids may activate the TLR4-mediated signaling in macrophages and participate in inducing insulin resistance 30, 31 . Interestingly, it was recently reported that mice deficient in either Nlrp3, caspase-1, or IL-1β and fed a normal-chow diet have improved insulin sensitivity, suggesting a role of the Nlrp3 inflammasome in regulating glucose homeostasis 32 . However, it remains unclear whether cytosolic pattern recognition receptors such as Nlrp3 have a role in sensing obesity-related danger signals or whether the Nlrp3 inflammasome participates in immune dysfunction leading to chronic inflammation and insulin resistance in diet-induced obesity. We show that Nlrp3 inflammasome activation in obesity promotes macrophage-mediated T cell activation in adipose tissue and impairs insulin sensitivity.
RESULTS

Nlrp3 is associated with obesity-induced insulin resistance
Our initial studies evaluated the expression of IL-1β and Nlrp3 in adipose tissue. We found that in mice the mRNA expression of Il1b and Nlrp3 in the visceral adipose tissue (VAT) correlated with body weight and adiposity (Fig. 1a,b) . Calorie restriction extends lifespan, reduces inflammation and enhances insulin sensitivity 33 , and therefore we examined whether calorie restriction affects the inflammasome transcriptional machinery in fat depots. Compared to ad libitum normal chow diet-fed control mice, chronic calorie restriction (40% reduction in food intake) in age-matched female mice (12 months old) resulted in a significant reduction (P < 0.01) in Nlrp3, Asc (also called Pycard) and Il1b mRNA in both VAT and subcutaneous adipose tissue (SAT) (Fig. 1c-e ) in parallel with a reduction in fat cell size (Fig. 1f,g ).
To test the clinical relevance of data generated from mouse models, we investigated obese individuals with type 2 diabetes mellitus (T2DM) before and after weight loss achieved by intensive behavioral modifications such as calorie restriction and exercise (Supplementary Table 1 ). The intervention was designed to achieve and maintain weight loss through decreased caloric intake and increased physical activity with an expected 1-year weight loss of ≥7% of the initial value 34 . The weight loss in obese subjects with T2DM resulted in substantial reduction in fat cell size and improvement of insulin sensitivity (Supplementary Table 1) . We collected abdominal SAT biopsies from obese male subjects of European descent with T2DM (n = 10) before and after 1 year of weight loss intervention. We conducted real-time PCR analysis to quantify the mRNA levels of NLRP3, ASC (PYCARD) and IL1B. To prevent observer bias, we did the analysis in a blinded fashion. The weight loss enhanced insulin sensitivity in obese individuals with T2DM, and this insulin sensitivity was associated with a significant reduction in IL1B and NLRP3 mRNA expression in SAT, with no change in PYCARD (Fig. 1h) . Of note, the reduction in IL1B and NLRP3 expression in SAT was coupled with lower glycemia and an improvement in homeostasis model assessment-insulin resistance (HOMA-IR) in these subjects ( Fig. 1i and Supplementary Table 1) . Together, these experiments indicate that the expression of NLRP3 inflammasome components is associated with adiposity and insulin resistance.
Inflammasome activation in obesity regulates IL-1b and IL-18
Nlrp3 is known to be present in several tissues and cell types 35 , but it is not known which cellular compartments in adipose tissue express the inflammasome components. Immunostaining of adipose tissue sections of obese mice revealed strong colocalization of Nlrp3 with the macrophage marker F4/80 (Fig. 2a) in crown-like structures. Consistent with the immunofluorescence data, examination of purified F4/80 + adipose tissue macrophages (ATMs), stromal vascular fraction (SVF) and mature 3T3-L1 adipocytes revealed that both Nlrp3 and Pycard are highly expressed in ATMs and SVF cells with low expression in adipocytes (Fig. 2b,c) . We also analyzed Nlrp3 expression in enriched primary adipocytes from adipose tissue of mice. Normalization of Nlrp3 mRNA expression with that of the differentiated macrophage marker Cd11c in the adipocyte fraction revealed that almost all Nlrp3 expression in enriched primary adipocytes may be attributed to contaminating lipid-engorged macrophages (data not shown). Notably, the development of progressive adiposity in high-fat diet (HFD)-fed mice led to strong caspase-1 autoactivation in adipose tissue ( Fig. 2d and Supplementary Fig. 1a,b) . Consistent with progressive caspase-1 activation in obesity, the highest expression of active IL-1β in adipose tissue was detected in 9-month-old dietinduced obese (DIO) mice (Fig. 2d) . Since we detected the most caspase-1 and IL-1β activation in 9-month-old DIO mice ( Fig. 2d  and Supplementary Fig. 2a) and because of the high prevalence of obesity and related comorbidities in the middle-aged population, we next studied the role of the Nlrp3 inflammasome in a chronic DIO model. This rationale is based on the hypothesis and our initial data (Fig. 2d ) that 28 weeks of HFD feeding in mice is likely to induce a more severe disease than 6-8 weeks of HFD feeding. Furthermore, although it is established that the Nlrp3 inflammasome regulates post-translational processing of caspase-1 in vitro in bone marrowderived macrophages 27, 28 , the specificity of this pathway for caspase-1 activation in vivo in different cell types in HFD-induced obesity is not established. Of note, compared to healthy, lean mice, obese mice had markedly more caspase-1 autoactivation in VAT, SAT and liver (Fig. 2e), (Supplementary Fig. 1 ). Ablation of Nlrp3 partially blocked the obesity-induced caspase-1 autoactivation in VAT, SAT and liver ( Fig. 2e and Supplementary Fig. 1 ) but did not affect caspase-1 cleavage in kidneys of chronic DIO mice (Fig. 2f) . These findings indicate that in obesity caspase-1 is specifically activated in adipose tissue and liver through an Nlrp3 inflammasome-dependent mechanism, but in kidney this process is independent of Nlrp3 and is tissue specific.
The post-translational processing of IL-1β is complex and can be regulated through several inflammasomes, including the Ipaf and AIM2 inflammasomes 19, 20 . Furthermore, pro-IL-1β can be processed through neutrophil-derived serine proteases in a caspase-1-and inflammasome-independent fashion 21, 36 . Our data show that, compared to wild-type (WT) mice, in DIO mice the ablation of the Nlrp3 inflammasome reduced the expression of active IL-1β in adipose tissue ( Fig. 2g and Supplementary Fig. 2b ). Normal chow-fed WT mice and Nlrp3-deficient mice did not show a difference in IL-1β 
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p17-IL-1β a r t i c l e s processing in VAT (data not shown). Notably, compared to normal chow-fed mice, obese mice had significantly higher serum IL-18 concentrations, which were blocked upon ablation of Nlrp3 (Fig. 2h) .
The serum concentrations of IL-1β in our WT and Nlrp3 −/− mice were below the detection limit of the ELISA (data not shown). These data indicate that the Nlrp3 inflammasome is specifically activated in response to HFD and controls the production of IL-1β in adipose tissue and IL-18 in obesity.
Nlrp3 inflammasome impairs insulin sensitivity in obesity
To further understand the role of the Nlrp3 inflammasome in regulating insulin action, we performed insulin and glucose tolerance tests (ITTs and GTTs) in WT and Nlrp3 −/− mice that had been fed a HFD, starting at 2 months of age, for 6 weeks, 4 months and 7 months. The ITTs and GTTs revealed that in early stages of obesity, the elimination of the Nlrp3 inflammasome affords substantial protection against HFD-induced insulin resistance (Fig. 3a) . In 6-month-old normal chow-fed control male mice, ablation of Nlrp3 did not alter insulin action (Supplementary Fig. 3a,b) or affect glucose homeostasis, suggesting specific activation of the Nlrp3 inflammasome in diet-induced obesity. Compared to 6-month-old WT DIO mice, Nlrp3 −/− mice showed a considerable reduction in glucose after insulin injection (Fig. 3b) , as well as an improvement in GTT (Fig. 3b) . Furthermore, compared to age-matched control WT mice, the 9-month-old obese Nlrp3 −/− mice (again, on HFD for 7 months) showed a significant reduction in fasting glucose levels ( Fig. 3c) as well as improved glucose homeostasis, as revealed by GTT (Fig. 3c) . Because of the lower baseline glucose values of Nlrp3 −/− mice (Fig. 3c) , the percentage reduction in glucose after insulin injection was not significantly different. Estimation of the area under the curve of ITT in 6-and 9-month-old DIO mice indicated a significant (P < 0.05) reduction in glucose concentrations in Nlrp3 −/− mice (Fig. 3d) . Consistent with an association of Nlrp3 with adipocyte size and insulin sensitivity in obese humans with T2DM (Supplementary Table 1), genetic ablation of Nlrp3 in mice was associated with a reduction in the fat cell size in VAT (Fig. 3e) but not in inguinal SAT (data not shown). Although the epididymal fat pad weight was lower in 3-month-old DIO Nlrp3 −/− mice than DIO WT control mice, the final body weights of male WT and Nlrp3 −/− mice after 6 weeks, 4 months and 7 months of 60% HFD (or normal chow diet) feeding did not show significant differences (Supplementary Fig. 4a,b) . We did not detect any change in blood triglyceride and cholesterol concentrations in middle-aged obese Nlrp3 −/− mice ( Supplementary Fig. 4c,d) .
Given that the metabolic effects of insulin are dependent on phosphoinositol 3-kinase (PI3K)-AKT signaling, we investigated the Ser473 phosphorylation of AKT as a readout of AKT activity after 5-min and 10-min insulin injection in 8-month-old obese WT (n = 9) and Nlrp3 −/− mice (n = 9). Consistent with higher insulin sensitivity, the Nlrp3 −/− mice had significantly greater (P < 0.05) AKT activity in VAT, SAT, liver and muscle compared to the insulin-treated obese WT control mice ( Fig. 3f and Supplementary Fig. 5 ), whereas vehicle-injected control mice did not show any AKT phosphorylation ( Supplementary  Fig. 6a ). Consistent with enhanced insulin sensitivity in the absence of the Nlrp3 inflammasome, there was also a reduction in serine phosphorylation of insulin receptor substrate-1 (IRS-1) in liver and fat of Nlrp3 −/− obese mice ( Fig. 3f and Supplementary Fig. 5e ).
Apart from the PI3K-AKT pathways, insulin can also signal by promoting the interaction of the adaptor protein growth factor receptor bound protein 2 (Grb2) with the son-of-sevenless protein to activate Ras-mitogen-activated protein kinase (MAPK) signaling 37 . Considering that the Ras-MAPK pathway primarily regulates the nonmetabolic effects of insulin such as cell growth, differentiation and survival 37 , we next tested the specificity of insulin signaling in Nlrp3 inflammasomedeficient obese mice. Notably, compared to control mice, we found marked activation of the MAPKs extracellular signal-regulated kinases 1 and 2 (Erk1/2) specifically in the VAT of DIO Nlrp3 −/− mice but not in SAT liver or muscle ( Fig. 3f and Supplementary Fig. 6b ). These data suggest that improvement of insulin sensitivity in Nlrp3-deficient mice is related to overall stimulation of the PI3K-AKT pathway, whereas the MAPK pathway is selectively activated in visceral fat.
Given that knockout of Nlrp3 results in a reduction in caspase-1 activation in the liver and also improvement in insulin signaling in liver, we also investigated hepatic steatosis in 9-month-old DIO Nlrp3 −/− mice. The histological evidence suggests that, compared to 9-month-old DIO WT mice, obese Nlrp3 −/− mice have reduced hepatic steatosis (Fig. 3g) , which is consistent with recent findings that activation of the Nlrp3 inflammasome induces hepatic fibrosis and liver injury 38, 39 . Furthermore, the reduction in fatty liver disease in obese Nlrp3 −/− mice was associated with an increase in fatty acid oxidation regulators enoyl-coenzyme A hydratase/3-hydroxyacyl coenzyme A dehydrogenase (encoded by Ehhadh), carnitine palmitoyltransferase 1a (Cpt1a) and carnitine acetyltransferase (Crat), with no change in mRNA expression of acetyl-coenzyme A carboxylase alpha (Acaca) and fatty acid synthase (Fasn) (data not shown), which are known to regulate fatty acid synthesis (Fig. 3h) .
Ceramides activate Nlrp3 inflammasome and ATMs in obesity
Inhibition of obesity-induced caspase-1 activation and insulin resistance in Nlrp3 −/− mice prompted us to investigate whether the Nlrp3 inflammasome senses specific inducers that activate innate immune cells such as macrophages. Recent evidence suggests that during progressive obesity the development of adipose tissue fibrosis restricts adipocyte expansion, which may ultimately cause lipid spillover in tissues and increases in circulating levels of free fatty acids 40 . Because ATMs can scavenge lipids, and generation of ceramide from fatty acids during obesity induces inflammation [41] [42] [43] [44] , we tested whether the Nlrp3 inflammasome senses ceramide. We primed bone marrow-derived macrophages (BMDMs) with lipopolysaccharide (LPS) to induce transcriptional activation of IL-1β, and secondary inflammasome activation signal was provided by ceramides as established previously 27, 28 . The immunoblot analysis revealed that, together with the positive control (LPS plus ATP), exposure of WT macrophages to ceramides causes activation of caspase-1 (Fig. 4a) . Notably, ceramide-induced caspase-1 activation was blocked in the absence of Nlrp3 (Fig. 4a) . Consistent with these data, we observed that ceramide-induced IL-1β secretion from macrophages was reduced in absence of Nlrp3 (Fig. 4b) .
Next, we investigated the physiological relevance of these data and tested whether ceramides can induce caspase-1 activation within adipose tissue. We cultured epididymal adipose tissue explants from 9-month-old WT DIO and Nlrp3 −/− DIO mice in the presence of LPS and ceramide. As in BMDMs, the LPS priming and ceramide-induced caspase-1 activation was reduced in adipose tissue explants of Nlrp3 −/− mice (Fig. 4c) . Considering that within adipose tissue, the ATMs highly express the Nlrp3 inflammasome components (Fig. 2b,c) , we investigated whether reduction of Nlrp3-mediated sensing of obesityassociated proinflammatory inducers affects the proinflammatory profiles of ATMs in vivo. The ATMs were enriched from the stromal vascular fraction (SVF) through positive selection of F4/80-expressing cells from VAT and SAT of 9-month-old control WT and Nlrp3 −/− All data are presented as means ± s.e.m., *P < 0.01, **P < 0.001. a r t i c l e s DIO mice. We found that loss of Nlrp3 function increased the expression of the M2 macrophage-associated transcripts interleukin-10 (encoded by Il10) and arginase (Arg1) in SAT ATMs but not in VAT macrophages (Fig. 4d) . These results suggest that obese Nlrp3 −/− mice specifically retain an M2-like macrophage phenotype in the inguinal SAT. In addition, we found that M1 macrophage-associated expression of tumor necrosis factor (Tnfa), chemokine (C-C motif) ligand 20 (Ccl20) and chemokine (C-X-C motif) ligand 11 (Cxcl11) were specifically reduced in the visceral fat-derived ATMs but not in SAT macrophages (Fig. 4d) . Also, the expression of Il10 was increased in SAT of Nlrp3 −/− mice, whereas Tnfa expression was reduced in obese Nlrp3-deficient mice (Supplementary Fig. 7 ). Compared to WT obese mice, the ATMs derived from the SAT of Nlrp3 −/− obese mice showed lower inducible nitric oxide synthase 2 (Nos2) expression ( Fig. 4d) . Collectively, these data suggest that ablation of Nlrp3 protects from obesity-associated proinflammatory ATM activation.
Nlrp3 inflammasome regulates adipose-T cells in obesity
In addition to macrophages, the expanded adipose tissue during obesity also harbors activated T cell populations that are thought to participate in local adipose tissue inflammation and insulin resistance [45] [46] [47] [48] . A reduction in adipose inflammation and improved insulin action due to Nlrp3 deficiency prompted us to investigate ATMs and adipose tissue T cell subsets. We found that in VAT of 9-month-old DIO mice, the loss of Nlrp3 function did not affect the frequency of M1 (F4/80 + CD11c + CD206 − ) or M2 (F4/ 80 + CD11c − CD206 + ) ATMs (Fig. 5a) . Notably, we observed reduced numbers of smaller cells (gate 2, on forward scatter (FSC) and side scatter (SSC), Fig. 5a ) in SVF of obese Nlrp3 −/− mice. Gating this population in SVF (gate 2) revealed that these cells are not ATMs (which are present in gate 1), as they lack expression of F4/80, CD11c and CD206. 
a r t i c l e s
Further examination of smaller cells in gate 2 within SVF revealed that in WT mice approximately 60% of these cells are T lymphocytes (Fig. 5b) . Compared to WT controls, 9-month-old Nlrp3-deficient mice did not show significant differences in the frequencies of CD4 + and CD8 + cells (Fig. 5b) . Furthermore, in 9-month-old obese mice, elimination of Nlrp3 inflammasome signaling did not affect the overall ratio (percentage gated) of CD4 + and CD8 + effector memory (CD62L − CD44 + ) or CD4 + and CD8 + naive T cell subsets (CD62L + CD44 − ) (Fig. 5b) . Compared to WT control mice, the ablation of Nlrp3 in 9-month-old DIO mice reduced the overall percentage of lymphocytes (in FSC and SSC gate 2) within the SVF of VAT (Fig. 5b) . The estimation of T cell numbers within SVF revealed that loss of Nlrp3 led to a significant (P < 0.05) reduction in the overall numbers of CD4 + T cells, CD4 + effector memory cells, CD8 + T cells and CD8 + effector memory cells without significant difference in naive T cells (Fig. 5c) . Consistent with these data, compared to WT DIO mice, Nlrp3-deficient obese mice had a significant reduction in the total number of SVF cells in the visceral fat at both early (3 month olds) and chronic (9 month olds) stages of obesity (Fig. 5d) .
Among various T cell subsets, the CD4 + CD25 + FoxP3 + T regulatory (T reg ) cells constitute a major defense mechanism to dampen the proinflammatory response in several autoimmune and infectious diseases 45 . Recent studies have shown that the number of antiinflammatory T reg cells in adipose tissue are reduced in obesity, and increasing the T reg cell number improves insulin action 45 . Analysis of T reg cells in visceral fat (epididymal and perirenal) and subcutaneous fat (inguinal) in middle-aged DIO mice revealed no significant differences between WT and Nlrp3-deficient mice (Fig. 5e,f) , suggesting that the Nlrp3-dependent effects on adipose tissue effector T cell subsets are specific.
Together with the VAT, the SAT also constitutes a substantial proportion of adipose mass in obese mice. Considering that obesityassociated caspase-1 autoactivation in SAT is Nlrp3 dependent, we next investigated whether the reduction in macrophage activation and insulin sensitivity is associated with changes in distribution of naive and effector memory adipose resident T cell subsets in subcutaneous fat. Notably, elimination of the Nlrp3 inflammasome in 9-month-old obese mice increased the number of M2 macrophages (F4/80 + CD11c − CD206 + ) without affecting the M1 macrophage (F4/80 + CD11c + CD206 − ) frequency (Fig. 6a,b) . Unexpectedly, compared to WT obese mice, the adipose tissue T cell number of both CD4 + and CD8 + cells was significantly higher in Nlrp3 −/− mice (Fig. 6c,d) . Notably, examination of total CD4 + and CD8 + cells revealed that there was a preponderance of naive cells (CD4 + CD62L + CD44 − , CD8 + CD62L + CD44 − ) within the adipose T cell compartment of Nlrp3-deficient DIO mice (Fig. 6c,d) , suggesting a lower inflammatory profile in fat.
Considering that macrophage-derived IL-18 induces a T helper1 (T H 1) response for host defense against specific infections, we also investigated the amount of IFN-γ expression, a classical T H 1-derived cytokine in the context of non-infectious sterile obesity-induced inflammation in Nlrp3-deficient mice. Consistent with the reduction in expression of obesity-induced IL-18 in Nlrp3 −/− mice (Fig. 2h) , ablation of the Nlrp3 inflammasome lowered the expression of Ifng mRNA, as well as protein, in adipose tissue during obesity (Fig. 6e,f) . Furthermore, in the absence of the Nlrp3 inflammasome, the obesityinduced increase in circulating interferon-γ-inducible protein (IP-10) and monocyte chemoattractant protein-1 (MCP-1) were significantly reduced (Fig. 6g) without any change in IL-17 abundance (data not shown). Collectively, the data suggest that blocking the activation of the Nlrp3 inflammasome in response to obesity-related danger signals may lower macrophage-T cell activation that participate in sustaining chronic inflammation (Fig. 6h) .
DISCUSSION
Obesity is associated with self-directed tissue inflammation where local or systemic factors other than infectious agents activate the cells of the innate immune system. Despite the evidence of skewed T cell receptor repertoire in obesity 4, 47, 48 , the evidence that sterile inflammation during obesity results from underlying autoimmune processes or due to the presence of organ-specific autoantibodies has so far not been definitively shown. Therefore, obesity-associated inflammation may qualify as autoinflammation, which was defined by McGonagle and McDermott as self-directed tissue inflammation, where local factors at disease-prone sites determine activation of the innate immune system 49 . The influx of macrophages as well as T cells in adipose tissue upon chronic caloric excess-driven obesity and release of proinflammatory mediators by these cells causes insulin resistance [6] [7] [8] [9] 31, [45] [46] [47] [48] . However, an upstream initiating event for obesity-induced immune cell activation in adipose tissue is not established. Here we have shown that the Nlrp3 inflammasome has a substantial role in sensing obesity-associated inducers of caspase-1 activation and therefore regulates development and the magnitude of inflammation and its downstream effects on insulin signaling.
Our findings that the adipose tissue expression of IL-1β and Nlrp3 inflammasome components are coupled with the development of insulin resistance and severity of T2DM in obese individuals raised several questions. First, can caspase-1 undergo autoactivation in obesity, and does eliminating the signaling through Nlrp3 reduce adipose inflammation and improve insulin action? We found that induction of HFD-induced obesity caused marked caspase-1 activation in adipose tissue and liver. Such a steady-state in vivo activation of caspase-1 in obesity has so far not been reported in the context of selfdirected tissue inflammation. The loss of Nlrp3 function reduced, but did not eliminate, the caspase-1 activation in visceral fat, subcutaneous fat and liver, suggesting that other inflammasomes may contribute to the pathophysiology of obesity. In addition, Nlrp3 inflammasome activation was tissue specific, as obesity-induced caspase-1 activation in kidney was not affected in Nlrp3-deficient mice. Consistent with these data, obese Nlrp3 −/− mice were more insulin sensitive.
What is being sensed by the Nlrp3 inflammasome to induce caspase-1 activation in obesity? This question is difficult to answer, particularly in a complex disorder such as diet-induced obesity where alterations in several cell stress-associated metabolites could potentially activate Nlrp3 or other inflammasomes (Fig. 6h) . It has been shown that saturated fatty acids such as oleate and palmitate can induce inflammation by TLR4 (ref. 30 ) and loss of TLR4 function can partially protect against obesity-induced insulin resistance 31 . Notably, obesity-related increased levels of lipotoxic ceramides can induce cell death and also trigger inflammation [41] [42] [43] [44] . Our data show that ceramides induce caspase-1 activation in an Nlrp3-dependent mechanism. However, it is possible that in diet-induced obesity several other inducers may participate in caspase-1 activation. For example, the Nlrp3 inflammasome has recently been shown to be activated by oxidized low-density lipoprotein and cholesterol crystals in models of HFD-induced atherogenesis, leading to macrophage activation and IL-1β secretion 50 . Cells undergoing necrosis can also activate the Nlrp3 inflammasome in macrophages 51 . Considering that the development of obesity is also associated with hypoxia 52 and adipocyte death 53 , it is likely that ATMs that form crown-like structures can be activated a r t i c l e s nature medicine VOLUME 17 | NUMBER 2 | FEBRUARY 2011 1 8 7
via the Nlrp3 sensing pathway. Furthermore, visceral adiposity and obesity are associated with an increase in monosodium urate (MSU) levels and increased risk of diabetes and atherosclerosis 54, 55 . Given that MSU is sensed by the Nlrp3 inflammasome and causes increased inflammation 28 , it is possible that MSU may be one of the danger signals sensed by the Nlrp3 inflammasome, thus contributing to obesityinduced disease. Further, it is also likely that reduced sensing of such DAMPs as a result of Nlrp3 deficiency protects from long-term obesity and hyperglycemia-associated insult (Fig. 6h) . Lastly, which mediators downstream of the Nlrp3 inflammasome participate in the mechanism of obesity-induced inflammation and insulin sensitivity? Although the Nlrp3 inflammasome specifically regulates caspase-1 activation, which allows the release of IL-1β and IL-18, both of these cytokines in turn can initiate several events that may amplify inflammatory responses 21 . Our prior studies have found that obesity is associated with an increase in the number of IFN-γ + T cells in the adipose tissue 48 . It is well known that IFN-γ alone or together with microbial stimuli (such as LPS) can cause induction of classically activated M1 macrophages 17 . In the context of obesityassociated inflammation, we provide the additional mechanistic insight that a reduction in IL-1β and IL-18 processing is regulated by the Nlrp3 inflammasome, which may deliver secondary signals to adipose tissue T cells and induce an effector T H 1 proinflammatory profile in adipose tissue. Consistent with our data of reduced IFN-γ expression in Nlrp3 −/− mice and improved insulin signaling in these mice, the ablation of IFN-γ is associated with improved metabolic outcomes in obesity 56 . Furthermore, increases in M1 macrophagederived cytokines and effector T cells in adipose tissue are causally linked to insulin resistance 8, [45] [46] [47] [48] . Together with our previous studies that show that purified adipose T cells produce several cytokines that further activate macrophages 48 , our present data show that elimination of the Nlrp3 inflammasome reduces M1-like macrophage gene expression and increases the expression of M2-like cytokines. Together these data suggest that the Nlrp3 inflammasome sensing pathway participates in the origin of inflammation in obesity by inducing macrophage and subsequent T cell activation (Fig. 6h) .
Notably, blocking the obesity-induced gain of Nlrp3 inflammasome function did not affect T reg cell homeostasis in adipose tissue but specifically reduced the numbers of effector memory cells and increased the naive CD4 + and CD8 + T cell populations. Consistent with our data, reduction in effector memory cells counts in VAT may be partly linked to a decrease in CCL20 and CXCL11 chemokine expression 57 . The improvement in overall metabolic profiles upon elimination of Nlrp3 signaling may also be related to less hepatic steatosis and regulation of genes that control hepatic fatty acid oxidation in obese mice. It has recently been reported that uric acidinduced release of reactive oxygen species facilitates the interaction of thioredoxin-interacting protein to Nlrp3, leading to IL-1β release 58 . Consistent with our findings, these studies also support a role of the Nlrp3 inflammasome in regulating glucose homeostasis 32, 58 .
It was recently reported that inflammasome-mediated caspase-1 processing in adipocytes impairs insulin sensitivity 32 . In our studies, we found that Nlrp3 and ASC expression in adipocytes, as compared to adipose tissue macrophages, was very low. In addition, we found that the high expression of Nlrp3 and ASC in primary adipocyte fractions of enzymatically digested adipose tissue may be attributable in large part to lipid-laden macrophages that contaminate enriched adipocyte fractions. Whether 3T3-L1 adipocytes or primary adipocytes can process procaspase-1 into active p20 and p10 heterodimers in response to specific signals via inflammasomes remains to be established.
Although TNF induces insulin resistance in vitro and in mice, the attempts to block TNF signaling in obese individuals with T2DM have so far yielded disappointing results 59 . In contrast, inhibiting IL-1β signaling by the IL-1 receptor antagonist anakinra can dampen systemic inflammation, including by decreasing circulating C-reactive protein and IL-6 and reducing type 2 diabetes in humans 12, 13 . Furthermore, widely used antidiabetic sulfonylurea drugs such as glyburide can also block Nlrp3 inflammasome activation and reduce mortality due to septic shock 60 . Taken together, our data establish that Nlrp3 inflammasomedependent post-translational processing of IL-1β and IL-18 in response to obesity-associated danger signals participates in the development of a chronic proinflammatory state that impairs insulin sensitivity. These findings highlight the potential of targeting the molecular pathways regulating caspase-1 activation in obesity for management of insulin resistance and chronic inflammationinduced comorbidities.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/. a r t i c l e s
